SCHEMBL26290377

SCHEMBL26290377

CC[C@H]1OC(O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10072851 0.85 — —
SCHEMBL12150948 0.84 CYP2D6 (0.32) —
SCHEMBL12150949 0.81 — —
SCHEMBL26290375 0.81 — —
SCHEMBL18073862 0.75 CXCL10 (0.30) —
SCHEMBL23113791 0.74 L3MBTL1 (0.35) —
SCHEMBL14262338 0.73 — —
SCHEMBL19317371 0.73 — —
SCHEMBL6809069 0.72 L3MBTL1 (0.34) —
SCHEMBL6809261 0.72 L3MBTL1 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230279035-A1 Novel Prodrugs Derived from Nicotinic Acid and Ribose MITOPOWER, INC. 2023-09-07 — — US disclosed
Send feedback